In 2011, John Klein founded Cambridge Therapeutics in Alpine, New Jersey, where he currently serves as chairman. Four years later, John Klein expanded his professional endeavors beyond Cambridge Therapeutics by founding Bilogix, LLC, an enterprise performance management (EPM) services provider also based in Alpine, NJ.
The EPM solution chain consists of five key points that can be optimized to address the needs of specific industries and vendors. Strategy and metrics visualization is the first step in the EPM solution chain and involves a number of strategy maps and business activity monitoring processes, along with the scorecards and dashboards often associated with EPM support. Enterprise planning and budgeting, meanwhile, can be described as the strategic integration of budgeting and forecasting applications with tactical enterprise planning efforts.
Financial modeling and analysis is another important part of the EPM solution chain and can be achieved through a range of processes, from cost and profitability modeling to cost and chargeback system. Business reporting processes along the EPM solution chain consist not only of comprehensive management reporting for customers but also options for optimized financial consolidation.
Finally, the EPM solution chain relies on a fully integrated performance management system, which allows for reporting on highly concentrated performance metrics.
Comments
Post a Comment